Stay updated on BMN165 Self-Injections in PKU Clinical Trial

Sign up to get notified when there's something new on the BMN165 Self-Injections in PKU Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BMN165 Self-Injections in PKU Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-14T01:58:04.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the efficacy and safety evaluation of self-administered injections of BMN165 by adults with Phenylketonuria (PKU) in a Phase 3 clinical trial.
    Difference
    0.1%
    Check dated 2024-06-06T16:00:00.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for study participants, specifying that individuals must have completed a prior BMN 165 study and meet various health and demographic requirements. Previously, no specific participation criteria information was provided.
    Difference
    36%
    Check dated 2024-05-22T13:13:43.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2024-04-30T22:57:41.000Z thumbnail image

Stay in the know with updates to BMN165 Self-Injections in PKU Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BMN165 Self-Injections in PKU Clinical Trial page.